AcquisitionOther
Eli Lilly and Company acquired Adverum Biotechnologies Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Eli Lilly and Company -> Adverum Biotechnologies Inc.
Acquire Adverum's neuroscience pipeline and expand gene therapy capabilities.
Open source record (SEC) ↗